iRadimed
IRMD
217 hedge funds and large institutions have $722M invested in iRadimed in 2025 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 65 increasing their positions, 72 reducing their positions, and 15 closing their positions.
233% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 15
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
86% more call options, than puts
Call options by funds: $742K | Put options by funds: $399K
47% more capital invested
Capital invested by funds: $492M → $722M (+$230M)
17% more funds holding
Funds holding: 185 → 217 (+32)
3.92% more ownership
Funds ownership: 54.42% → 58.35% (+3.9%)
10% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 72
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$28.6M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$17.7M |
| 3 |
Goldman Sachs
New York
|
+$4.75M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$4.73M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$29.4M |
| 2 |
Millennium Management
New York
|
-$8.15M |
| 3 |
Renaissance Technologies
New York
|
-$2.78M |
| 4 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
-$1.8M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$1.72M |
IRMD Hedge Fund Activity: Q4 2025 in Review
217 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2025, worth a combined $722M — up 47% from $492M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new IRMD positions and 15 closed out — a net gain of 35 holders — while 65 added to existing stakes and 72 trimmed.
The largest buyer was Kayne Anderson Rudnick Investment Management, opening a new position worth an estimated $28.6M. The largest seller was Nine Ten Capital Management, cutting an estimated $29.4M.
- 217 institutional investors held iRadimed (IRMD) as of Q4 2025, up from 185 in Q3 2025.
- Funds reported $722M of iRadimed stock for Q4 2025, up 47% quarter-over-quarter.
- 50 funds opened new iRadimed positions in Q4 2025 and 15 closed out, a net change of +35 holders.
- The largest iRadimed buyer in Q4 2025 was Kayne Anderson Rudnick Investment Management, an estimated $28.6M added.
- The largest iRadimed seller in Q4 2025 was Nine Ten Capital Management, an estimated $29.4M sold.
Based on aggregated 13F filings for Q4 2025.